{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:00:32Z","timestamp":1784815232498,"version":"3.55.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017238","name":"Sir Run Run Shaw Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The maximum diameter of metastatic lymph node (LNM) foci serves as a core indicator for individualized postoperative management of papillary thyroid carcinoma (PTC). The 2015 ATA guidelines adopt 0.2\u00a0cm as a cutoff value to distinguish clinically significant lymph node metastasis (LNM, \u22650.2 cm) from LNM micrometastasis (&amp;lt;0.2\u00a0cm), with distinct follow-up regimens and adjuvant radioactive iodine (\u00b9\u00b3\u00b9I) therapy indications for the two groups. Existing predictive models only judge the presence or absence of preoperative LNM, lacking dedicated risk stratification tools for pathologically confirmed pN1 patients to quantify nodal metastatic tumor burden. Conventional maximum-likelihood logistic regression is prone to complete data separation and extreme odds ratio (OR) inflation when analyzing low-prevalence pathological markers such as extranodal extension (ENE). To resolve this methodological limitation, we developed a predictive nomogram based on L2 ridge penalized logistic regression using postoperative paraffin-embedded pathological data only.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To screen independent pathological predictors of \u22650.2 cm clinically significant LNM in patients with classical pN1 PTC, construct a visualized postoperative risk stratification nomogram, and improve the statistical robustness of predictive models built on sparse pathological datasets via L2 ridge penalized logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center retrospective study enrolled 212 patients with pathologically confirmed classical pN1 PTC who underwent surgical resection from January 2021 to December 2025. Subjects were divided into a micrometastasis group (n = 92, maximum metastatic lesion diameter&amp;lt; 0.2\u00a0cm) and a clinically significant LNM group (n = 120, maximum metastatic lesion diameter \u2265 0.2\u00a0cm). All 13 clinicopathological indicators were included in univariate L2 ridge penalized logistic regression; variables with P&amp;lt; 0.01 were entered into the multivariate model. The optimal regularization parameter C\u00a0=\u00a00.05 was selected by combining ridge trace plots and 10-fold cross-validation, and variance inflation factor (VIF) analysis was performed to detect multicollinearity. Model performance was comprehensively evaluated by ROC curves, AUC value, Hosmer\u2013Lemeshow goodness-of-fit test, calibration curves and decision curve analysis (DCA). A total of 1,000 bootstrap resamples were adopted for internal validation, and leave-one-variable-out sensitivity analysis was conducted to evaluate model robustness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>LNmet, ENE, thyroid capsular invasion (TCI), intrathyroidal dissemination (ITD), primary tumor size, and age were significant univariate predictors, yet age lost predictive value after adjustment. Adjusted ORs were LNmet (3.02), ENE (2.94), TCI (1.83), ITD (1.75), and tumor size (1.33). The model achieved an AUC of 0.839 (Hosmer\u2013Lemeshow P\u00a0=\u00a00.155). Bootstrap validation confirmed stable coefficients without extreme OR inflation. DCA showed net clinical benefit across the 0.2\u20130.8 threshold range; however, these findings do not support extended lymphadenectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This L2 ridge nomogram effectively stratifies postoperative \u22650.2 cm LNM risk and guides personalized surveillance and \u00b9\u00b3\u00b9I therapy. It is not intended for preoperative evaluation or surgical planning, and its generalizability requires external multicenter validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1848554","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:00:51Z","timestamp":1784811651000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Nomogram for postoperative pathological stratification of \u22650.2 cm clinically significant lymph node metastasis burden in pN1 papillary thyroid carcinoma: development and validation using L2 ridge penalized logistic regression"],"prefix":"10.3389","volume":"17","author":[{"given":"Luyan","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pathology, Alar Hospital of Sir Run Run Shaw Hospital, Zhejiang University","place":["Alar, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fucong","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pathology, Alar Hospital of Sir Run Run Shaw Hospital, Zhejiang University","place":["Alar, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Alar Hospital of Sir Run Run Shaw Hospital, Zhejiang University","place":["Alar, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Pathology, Alar Hospital of Sir Run Run Shaw Hospital, Zhejiang University","place":["Alar, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinli","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Pathology, Alar Hospital of Sir Run Run Shaw Hospital, Zhejiang University","place":["Alar, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Alar Hospital of Sir Run Run Shaw Hospital, Zhejiang University","place":["Alar, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Pathology, Alar Hospital of Sir Run Run Shaw Hospital, Zhejiang University","place":["Alar, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1295548","article-title":"Meta-analysis of the effect and clinical significance of delphian lymph node metastasis in papillary thyroid cancer","volume":"14","author":"Chen","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035045","article-title":"Analysis of the influence factors of cervical lymph node metastasis in papillary thyroid carcinoma: a retrospective observational study","volume":"102","author":"Lou","year":"2023","journal-title":"Med (Baltimore)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/er.2017-00067","article-title":"Controversies in the management of low-risk differentiated thyroid cancer","volume":"38","author":"Haymart","year":"2017","journal-title":"Endocr Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2217\/fon.16.10","article-title":"Nodal metastases in thyroid cancer: prognostic implications and management","volume":"12","author":"Wang","year":"2016","journal-title":"Future Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines tasfk orce on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"B7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12957-022-02573-7","article-title":"Clinicopathologic predictors of central lymph node metastases in clinical node-negative papillary thyroid microcarcinoma: a systematic review and meta-analysis","volume":"20","author":"Wen","year":"2022","journal-title":"World J Surg Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2018-0583","article-title":"Size of the largest metastatic focus to the lymph node is associated with incomplete response of pN1 paplllary thyroid carcinoma","volume":"25","author":"Deng","year":"2019","journal-title":"Endocr Pract"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1047","article-title":"A solution to the problem of separation in logistic regression","volume":"21","author":"Heinze","year":"2002","journal-title":"Stat Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2307\/2347628","article-title":"Ridge estimators in logistic regression","volume":"41","author":"Cessie","year":"1992","journal-title":"J R Stat Soc Ser C Appl Stat"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.0043","article-title":"The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension","volume":"22","author":"Randolph","year":"2012","journal-title":"Thyroid"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14030272","article-title":"The impact of total tumor diameter on lymph node metastasis and tumor recurrence in papillary thyroid carcinomas","volume":"14","author":"Can","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/jso.24713","article-title":"Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma","volume":"116","author":"Roh","year":"2017","journal-title":"J Surg Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1138085","article-title":"Central and lateral neck involvement in papillary thyroid carcinoma patients with or without thyroid capsular invasion: a multi-center analysis","volume":"14","author":"Yang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1428274","article-title":"Intraglandular dissemination: a special pathological feature","volume":"14","author":"Zhang","year":"2024","journal-title":"Front Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1034047","article-title":"A lasso-based model to predict central lymph node metastasis in preoperative patients with cN0 papillary thyroid cancer","volume":"13","author":"Zhao","year":"2023","journal-title":"Front Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1552479","article-title":"A machine learning-based model for predicting recurrence in intermediate- and high-risk differentiated thyroid cancer: insights from a retrospective single-center study of 2388 patients","volume":"16","author":"Li","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.8391","article-title":"Presence and number of lymph node metastases are associated with compromised survival for patients younger than age 45 years with papillary thyroid cancer","volume":"33","author":"Adam","year":"2015","journal-title":"J Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.759049","article-title":"Extranodal extension is an independent prognostic factor in papillary thyroid cancer: a propensity score matching analysis","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12957-024-03565-5","article-title":"Risk factor analysis and prediction model construction for contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma: sex, extrathyroidal tumor extension (ETE), tumor diameter and ipsilateral central lymph node metastasis (ICLNM) are risk factors for unilateral papillary thyroid carcinoma (UPTC): a case control study","volume":"22","author":"Qin","year":"2024","journal-title":"World J Surg Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01591","article-title":"An ultrasound radiomics nomogram for preoperative prediction of central neck lymph node metastasis in papillary thyroid carcinoma","volume":"10","author":"Zhou","year":"2020","journal-title":"Front Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.713475","article-title":"Preoperatively predicting the central lymph node metastasis for papillary thyroid cancer patients with Hashimoto's thyroiditis","volume":"12","author":"Min","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1570811","article-title":"Ultrasound-based artificial intelligence for predicting cervical lymph node metastasis in papillary thyroid cancer: a systematic review and meta-analysis","volume":"16","author":"Wang","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1385167","article-title":"Utilizing machine learning for early screening of thyroid nodules: a dual-center cross-sectional study in China","volume":"15","author":"Weng","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2017.0092","article-title":"Ultrasound features of extranodal extension in the metastatic cervical lymph nodes of papillary thyroid cancer: a case-control study","volume":"15","author":"Mu","year":"2018","journal-title":"Cancer Biol Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2020.02.003","article-title":"Invasion in thyroid cancer: controversies and best practices","volume":"37","author":"Nishino","year":"2020","journal-title":"Semin Diagn Pathol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102007","article-title":"Deep learning to predict cervical lymph node metastasis from intraoperative frozen section of tumour in papillary thyroid carcinoma: a multicentre diagnostic study","volume":"60","author":"Pang","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1484838","article-title":"The diagnosis and management of small and indeterminate lymph nodes in papillary thyroid cancer: preoperatively and intraoperatively","volume":"15","author":"Hu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"Cooper","year":"2009","journal-title":"Thyroid"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14737140.2025.2600641","article-title":"The prognostic significance of lymph node metastases characteristics in papillary thyroid carcinoma: a scoping review","volume":"12","author":"Dhutt","year":"2025","journal-title":"Expert Rev Anticancer Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2025.12.003","article-title":"Prognostic value of BRAF V600E mutation in papillary thyroid carcinoma: a meta-analysis of nodal involvement, distant metastases, recurrence, and mortality","volume":"32","author":"Gatta","year":"2026","journal-title":"Endocr Pract"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.5094","article-title":"BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence","volume":"32","author":"Xing","year":"2014","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1848554\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:00:52Z","timestamp":1784811652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1848554\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":34,"alternative-id":["10.3389\/fendo.2026.1848554"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1848554","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"article-number":"1848554"}}